Can You Take Green Tea Extract (EGCG) with Prometrium?

Prometrium is the brand name for oral micronized progesterone, FDA-approved for endometrial protection in women taking estrogen therapy and for secondary amenorrhea. Green tea extract is a dietary supplement standardized to catechins, the most studied of which is epigallocatechin-3-gallate (EGCG). No clinical trial has tested this specific combination, so the honest answer sits between "generally fine" and "no data": the mechanistic overlap is real, the more established risk is EGCG's own dose-dependent liver signal, and neither point has been confirmed in progesterone users specifically.

The direct answer

There is no FDA warning, drug label statement, or published clinical study describing an interaction between green tea extract/EGCG and Prometrium. What exists is indirect: EGCG is a laboratory-demonstrated inhibitor of CYP3A4 and CYP1A2, the enzymes that metabolize progesterone, and concentrated EGCG supplements carry an independent, dose-related liver-injury signal that regulators have flagged separately from any drug interaction. For most women taking standard-dose green tea extract (roughly 200 to 400 mg EGCG daily) with a typical Prometrium regimen, the theoretical interaction is unlikely to be clinically noticeable, but this has not been tested directly and should not be treated as proven safe at every dose or in every liver-health status.

Why these two overlap at all

Oral micronized progesterone undergoes substantial first-pass metabolism in the liver, primarily through CYP3A4, with smaller contributions from other CYP enzymes. This is described in the FDA prescribing information for Prometrium. EGCG has been shown in vitro to inhibit CYP3A4 and CYP1A2 activity, which is the pharmacologic basis for concern about herb-drug interactions involving green tea extract more broadly. In vitro inhibition does not automatically translate into a meaningful change in blood levels of a co-administered drug; that depends on the actual plasma concentration the supplement produces relative to the concentration needed to meaningfully block the enzyme, protein binding, and first-pass effects. That translation has not been measured for progesterone and EGCG together, so any statement about how much progesterone levels might rise in a real person is an extrapolation, not a measured finding.

The more established concern: EGCG and the liver

Independent of any interaction with progesterone, concentrated green tea extract has an established, dose-related hepatotoxicity signal. Regulatory and toxicology reviews (including work summarized by the European Food Safety Authority) have concluded that high daily intakes of EGCG from supplements, generally cited in the range of 800 mg per day and above, are associated with elevated liver enzymes and, in case reports, clinically apparent liver injury. This signal is specific to concentrated extract capsules taken as a bolus dose, not to brewed tea, which delivers EGCG gradually and in far smaller amounts per serving. Because Prometrium itself is cleared through hepatic first-pass metabolism, a woman with reduced liver reserve, pre-existing liver disease, or another hepatotoxic exposure has less margin if she also takes a high-dose EGCG product.

We are flagging this deliberately: the precise dose thresholds and case counts often cited for EGCG hepatotoxicity vary by source and need verification against the primary literature before being presented as a fixed number in patient-facing material. What is consistent across reviews is the direction of the finding (concentrated extract, higher dose, greater risk) even where the exact cutoff is debated.

What is established, what is plausible, and what is not established

Evidence-status interaction assessment: EGCG (green tea extract) and Prometrium (micronized progesterone)

If you are a clinician or pharmacist reviewing this for a patient, the items to verify before making a specific dose recommendation are: the patient's total daily EGCG intake across all products (including combination supplements that don't list EGCG prominently), baseline liver function, any other CYP3A4-dependent medications she takes, and whether she has any condition (fatty liver, hepatitis, prior drug-induced liver injury) that lowers her hepatic reserve.

What this means in practice

Because no trial has tested this combination, guidance here is necessarily general and conservative rather than a validated protocol.

If you use brewed green tea rather than a capsule, the interaction question is largely moot. Brewed tea delivers EGCG gradually in amounts well below the doses associated with liver injury in the toxicology literature, and population data have not shown a hepatotoxicity signal from tea drinking itself.

If you use a concentrated EGCG extract capsule, know your actual daily EGCG dose (check the label; some products deliver 500 mg or more per serving), favor lower-dose products, take the supplement with food rather than fasting, and avoid stacking it with other supplements or medications that also stress the liver or also depend heavily on CYP3A4 for clearance (certain statins, some calcium channel blockers, and some benzodiazepines are examples worth reviewing with a pharmacist).

If you have pre-existing liver disease, a history of drug-induced liver injury, or you are over 65 (when hepatic CYP3A4 activity tends to decline with age), the case for caution with concentrated extract is stronger, and a conversation with your prescribing clinician before starting or continuing a high-dose EGCG product is reasonable.

Watch for symptoms, not just labs. Nausea, right upper quadrant discomfort, unusual fatigue, dark urine, or yellowing of the skin or eyes warrant stopping the supplement and contacting your clinician promptly rather than waiting for a scheduled lab draw. Increased sedation, breast tenderness, or bloating after starting an EGCG supplement could theoretically reflect slowed progesterone clearance, though this has not been documented in published case reports for this specific pairing.

When to involve your clinician or pharmacist

Baseline liver function testing before starting a concentrated EGCG supplement, and a repeat check some weeks later, is a reasonable and low-burden precaution for anyone on a hepatically cleared medication like Prometrium, even though this specific combination has not been studied in a trial. Bring the exact product and dose to your pharmacist or prescriber rather than describing it as "green tea supplement," since EGCG content varies widely between products advertised as green tea extract.

Bottom line

The overlap between EGCG's enzyme inhibition and progesterone's metabolic pathway is real at the laboratory level, but no study has measured whether it changes progesterone exposure in people taking Prometrium. The better-supported concern is EGCG's own dose-dependent liver signal, which is a property of concentrated extract capsules rather than brewed tea. Treat specific numeric thresholds in this space as reasonable starting points for a conversation with a clinician or pharmacist, not as validated rules, until primary-source verification and, ideally, combination-specific data become available.